72
Participants
Start Date
August 31, 2011
Primary Completion Date
October 31, 2011
Study Completion Date
December 31, 2011
Thymosin beta 4
A preservative-free, sterile eye drop solution containing 0.1% (w/w) Tβ4 for direct instillation into each eye, twice a day (BID) for 28 days.
Placebo
A preservative-free, sterile eye drop solution containing 0.0% (w/w) Tβ4 for direct instillation into each eye, twice a day (BID) for 28 days.
ORA, Inc.
INDUSTRY
ReGenTree, LLC
INDUSTRY